Billings Clinic Resident Poster Session Information

To be submitted to the MPC Conference Coordinator by October 1, 2025

• Presenter information
  • Completed profile
  • Presenter release forms

To be submitted to the Billings Clinic Psychiatry Residency Education Director by October 15, 2025

• Poster title (maximum of 150 characters, with spaces)
  • Title should be brief, unique, and interesting
• Overall poster abstract (maximum of 3,000 characters, with spaces)
  • The abstract should be a concise description of results, findings, and conclusions.
  • Poster abstracts must include complete data analysis and results. Posters without results will be rejected, even if data are expected to be completed by the meeting.
  • Please do not include any references, citations, tables, or figures in your abstract.
  • Accepted poster abstracts will be published as-is in the meeting syllabus and proceedings. Please proofread your abstract before submitting.
• References
  • List three or more peer-reviewed references published in the last five years to support your session content.
  • References may be formatted according to your preferred style guide.
• Topic
  • Select one to two topics that best describe the overall focus of your proposed session.

• Posters present new research and case findings
• Literature review posters may also be presented, but must clearly state the methods, databases, and keywords used in the review and summarize how the review adds to existing literature on the subject
• Posters on single case studies will not be accepted
• Study data must be complete before the presentation and must be included within the submitted poster abstract
• Only one presenter per poster
• Maximum four co-authors per poster (co-authors do not present)
• One co-author may be designated as the "lead author." Unless otherwise noted, the poster presenter is assumed to be the lead author.

• There may only be one presenter for each poster and the presenter must be an investigator on the research study and included among the authors listed on the abstract submission.
• Research scientists/authors who are pharmaceutical company employees are eligible to present a poster. However, pharmaceutical representatives (e.g., sales and marketing staff) are prohibited from presenting the poster or assisting during the poster presentation.
• Posters must report only findings of the research. No advertising or product identification by brand name is allowed. If any or all of the work in this poster was prepared with commercial support, a statement “Supported by funding from [name of company]” must be noted in the lower left corner of the poster in Arial 72 point font, with no bold, italics, special colors, or other enhancement of the company name, product, or any other portions of the statement.
• Generic names of drugs should be used throughout the poster; if brand names must be used, they must be used for all products referenced.
• Information regarding unapproved uses of approved products or investigational uses of unapproved products must be clearly presented with the following statement included on the poster: “The following information concerns a use that has not been approved by the U.S. Food and Drug Administration.”
• The presenter must wear only their MPC name badge and not badges or insignia of companies. No company or product identification may be included on badges or otherwise worn by the investigator.
• The presenter may not engage in product detailing and may not direct participants to particular exhibits at the conference or other company-sponsored non-CME activities such as Product Theaters, or otherwise “market” the company or any product.
• Research results reported on the poster may not be displayed or distributed at the conference by industry representatives or as part of a booth in the exhibit hall.
• No CD-ROM or bound books may be distributed.
• Handouts must be limited to a one-page photocopy of your poster. The handouts must include the disclosure information on the funding of the research: “The research reported here was supported by [name of company].” Generic names of drugs should be used throughout in the handout. Any information regarding unapproved uses of approved products or investigational uses of unapproved products must include the following statement: “The following information concerns a use that has not been approved by the U.S. Food and Drug Administration.”

• The poster board surface area is 4’ high and 8’ wide. Your printed poster must fit within the poster board surface, but need not fill the entire area.
• Your poster must contain the abstract title and the name(s) of the poster author(s). The lettering for this section should be at least 1” high.
• A copy of your abstract, in large typescript, should be posted in the upper left-hand corner of the poster board.
• Photos of slides or hand-drawn charts and illustrations similar to slides may be individually arranged on the poster board surface, using push pins provided by the MPC in the poster area. Please note these push pins are to be shared by everyone. You may also arrange your presentation on lightweight construction paper ahead of time and mount the whole layout with four push pins.
• Prepare and bring with you all illustrations needed for your presentations, i.e., figures, tables, schemes, equations, etc.
• QR codes may be included on posters and handouts so long as the code does not lead to a website or materials promoting or marketing a company or product or otherwise violate any restrictions under “Guidelines for Poster Presentations” above.

Ideally, your poster should be self-explanatory so that you are free to supplement and discuss particular points when asked. The poster session provides an opportunity for informal discussion, but this becomes more difficult if you are obliged to explain the basics of your poster to each viewer.

• Bear in mind that your illustrations will be viewed from distances of 3 feet or more. All lettering should be at least 3/8” high, preferably in bold type.
• It helps the viewer if you can indicate (by numbers, letters, or arrows) a preferred sequence that might be followed in studying your material.
• Try to keep everything simple. Avoid “artsy” or overly ornate presentations. Block coloring can be useful here to add emphasis and clarity. Preferably, captions should be brief and labels few but clear.
• PLEASE  DO NOT WRITE OR PAINT ON THE POSTER BOARDS.
• The poster area will not have projection equipment or electrical outlets. Wireless internet will be available.